Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Mary Margaretten is active.

Publication


Featured researches published by Mary Margaretten.


Arthritis Care and Research | 2011

Socioeconomic determinants of disability and depression in patients with rheumatoid arthritis

Mary Margaretten; Jennifer L. Barton; Laura Julian; Patricia P. Katz; Laura Trupin; Chris Tonner; Jonathan Graf; John B. Imboden; Edward H. Yelin

To examine the relationship between functional limitation, socioeconomic inequality, and depression in a diverse cohort of patients with rheumatoid arthritis (RA).


International Journal of Clinical Rheumatology | 2011

Depression in patients with rheumatoid arthritis: description, causes and mechanisms.

Mary Margaretten; Laura Julian; Patricia P. Katz; Edward H. Yelin

Two sets of contributory factors to depression among patients with rheumatoid arthritis (RA) are generally examined - the social context of the individual and the biologic disease state of that persons RA. This article will review the evidence for both. RA affects patients both physically and psychologically. Comorbid depression is common with RA and leads to worse health outcomes. Low socioeconomic status, gender, age, race/ethnicity, functional limitation, pain and poor clinical status have all been linked to depression among persons with RA. Systemic inflammation may also be associated with, cause, or contribute to depression in RA. Understanding the socioeconomic factors, individual patient characteristics and biologic causes of depression in RA can lead to a more comprehensive paradigm for targeting interventions to eliminate depression in RA.


Biological Psychiatry | 2015

Elevated Risk for Autoimmune Disorders in Iraq and Afghanistan Veterans with Posttraumatic Stress Disorder

Aoife O’Donovan; Beth E. Cohen; Karen H. Seal; Dan Bertenthal; Mary Margaretten; Kristen Nishimi; Thomas C. Neylan

BACKGROUND Posttraumatic stress disorder (PTSD) is associated with endocrine and immune abnormalities that could increase risk for autoimmune disorders. However, little is known about the risk for autoimmune disorders among individuals with PTSD. METHODS We conducted a retrospective cohort study of 666,269 Iraq and Afghanistan veterans under age 55 who were enrolled in the Department of Veterans Affairs health care system between October 7, 2001, and March 31, 2011. Generalized linear models were used to examine if PTSD, other psychiatric disorders, and military sexual trauma exposure increased risk for autoimmune disorders, including thyroiditis, inflammatory bowel disease, rheumatoid arthritis, multiple sclerosis, and lupus erythematosus, adjusting for age, gender, race, and primary care visits. RESULTS PTSD was diagnosed in 203,766 veterans (30.6%), and psychiatric disorders other than PTSD were diagnosed in an additional 129,704 veterans (19.5%). Veterans diagnosed with PTSD had significantly higher adjusted relative risk (ARR) for diagnosis with any of the autoimmune disorders alone or in combination compared with veterans with no psychiatric diagnoses (ARR = 2.00; 95% confidence interval, 1.91-2.09) and compared with veterans diagnosed with psychiatric disorders other than PTSD (ARR = 1.51; 95% confidence interval, 1.43-1.59; p < .001). The magnitude of the PTSD-related increase in risk for autoimmune disorders was similar in women and men, and military sexual trauma exposure was independently associated with increased risk in both women and men. CONCLUSIONS Trauma exposure and PTSD may increase risk for autoimmune disorders. Altered immune function, lifestyle factors, or shared etiology may underlie this association.


Arthritis Care and Research | 2009

Predictors of depression in a multiethnic cohort of patients with rheumatoid arthritis

Mary Margaretten; Edward H. Yelin; John B. Imboden; Jonathan Graf; Jennifer L. Barton; Patricia P. Katz; Laura Julian

OBJECTIVE Patients with rheumatoid arthritis (RA) who experience depression have worse health outcomes. This study identifies predictors of depression in an ethnically and racially diverse population of patients with RA. METHODS Patients with RA in a prospective cohort at the San Francisco General Hospital outpatient rheumatology clinic were included if they were age >or=18 years, met the American College of Rheumatology classification criteria for RA, had a Health Assessment Questionnaire (HAQ) score collected, and had the RA-specific Disease Activity Score performed by a rheumatologist. The outcome variable was a depression score measured by the Patient Health Questionnaire 9 (PHQ-9), a self-report questionnaire validated to correlate with a diagnosis of major depression. RESULTS Three hundred forty-nine clinical visits for 172 patients were included in the analysis. Forty percent of patients scored >or=10 on the PHQ-9 during at least one clinic visit, which corresponds to a symptom severity of at least moderate depression. The mean PHQ-9 score was 7, corresponding to a symptom severity of mild depression. In the multivariate analysis, higher HAQ scores were associated with depression, and Asians had lower depression scores compared with Hispanic, white, and African American subjects. CONCLUSION Identifying associated predictors of depression in a diverse population of patients with RA can help guide treatment, which should include preventing disability and decreased function as well as targeting depressive symptoms more specifically in patients with RA.


Arthritis Care and Research | 2013

Choosing wisely: The American College of Rheumatology's top 5 list of things physicians and patients should question

Jinoos Yazdany; Gabriela Schmajuk; Mark L. Robbins; David I. Daikh; Ashley Beall; Edward H. Yelin; Jennifer L. Barton; Adam Carlson; Mary Margaretten; JoAnn Zell; Lianne S. Gensler; Victoria M Kelly; Kenneth G. Saag; Charles H. King

We sought to develop a list of 5 tests, treatments, or services commonly used in rheumatology practice whose necessity or value should be questioned and discussed by physicians and patients.


Arthritis Care and Research | 2011

Racial and ethnic disparities in disease activity and function among persons with rheumatoid arthritis from university-affiliated clinics

Jennifer L. Barton; Laura Trupin; Dean Schillinger; Stuart A. Gansky; Chris Tonner; Mary Margaretten; Vladimir Chernitskiy; Jonathan Graf; John B. Imboden; Edward H. Yelin

Health outcomes in rheumatoid arthritis (RA) have improved significantly over the past 2 decades. However, research suggests that disparities exist by race/ethnicity and socioeconomic status, with certain vulnerable populations remaining understudied. Our objective was to assess disparities in disease activity and function by race/ethnicity and explore the impact of language and immigrant status at clinics serving diverse populations.


Arthritis Care and Research | 2013

Sex differences in assessment of obesity in rheumatoid arthritis

Patricia P. Katz; Jinoos Yazdany; Laura Trupin; Gabriela Schmajuk; Mary Margaretten; Jennifer L. Barton; Lindsey A. Criswell; Edward H. Yelin

To determine the prevalence of obesity and how accurately standard anthropometric measures identify obesity among men and women with rheumatoid arthritis (RA).


Arthritis Care and Research | 2015

Sleep disturbance, depression, obesity, and physical inactivity explain a significant portion of fatigue in rheumatoid arthritis

Patricia P. Katz; Mary Margaretten; Laura Trupin; Gabriela Schmajuk; Jinoos Yazdany; Edward H. Yelin

Fatigue is a major concern for individuals with rheumatoid arthritis (RA). However, in order to treat fatigue adequately, its sources need to be identified.


Clinical Toxicology | 2010

Massive acetaminophen ingestion with early metabolic acidosis and coma: treatment with IV NAC and continuous venovenous hemodiafiltration.

Timothy J. Wiegand; Mary Margaretten; Kent R. Olson

Context. We report the extraction of acetaminophen by continuous venovenous hemodiafiltration (CVVHD) during treatment of an acute ingestion of 200 g with a peak recorded serum acetaminophen level of 1,614 mg/L (10,652 μmol/L). Case details. The patient presented with early onset of coma, metabolic acidosis, and hypotension in the absence of significant hepatic injury. In addition to N-acetylcysteine (NAC) therapy, CVVHD was performed to manage the acid–base disturbance. Flow rate, effluent volume, and serum and effluent drug concentrations were obtained at hourly intervals. During 16 h of CVVHD the acetaminophen level dropped from 1,212 to 247 mg/L. Discussion. The average clearance of acetaminophen by CVVHD was 2.53 L/h, with removal of 24 g of acetaminophen over 16 h. As NAC is effective in preventing hepatic injury after acute acetaminophen overdose, the role of dialysis or CVVHD is limited.


Arthritis Care and Research | 2016

Role of Sleep Disturbance, Depression, Obesity, and Physical Inactivity in Fatigue in Rheumatoid Arthritis

Patricia P. Katz; Mary Margaretten; Laura Trupin; Gabriela Schmajuk; Jinoos Yazdany; Edward H. Yelin

Fatigue is a major concern for individuals with rheumatoid arthritis (RA). However, in order to treat fatigue adequately, its sources need to be identified.

Collaboration


Dive into the Mary Margaretten's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Jinoos Yazdany

University of California

View shared research outputs
Top Co-Authors

Avatar

Laura Trupin

University of California

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Jonathan Graf

University of California

View shared research outputs
Top Co-Authors

Avatar

Laura Julian

University of California

View shared research outputs
Top Co-Authors

Avatar

Stephen Bent

University of California

View shared research outputs
Researchain Logo
Decentralizing Knowledge